FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Fresenius Pays $231 Million to Resolve Corrupt Schemes

Fresenius Medical Care agrees to pay $231 million to resolve investigations by the Department of Justice and the Securities and Exchange Commission in...

Federal Register

Bacillus Species IVDs Put Into Class 2

Federal Register notice: FDA issues a final rule to classify in vitro diagnostic devices for Bacillus species detection into Class 2 (special controls...

Federal Register

Class 2 for Posterior Cervical Screw Systems

Federal Register notice: FDA issues a final rule to classify posterior cervical screw systems into Class 2 (special controls) and to continue to requi...

Federal Register

Editorial Changes to Device Corrections/Removals Reg

Federal Register notice: FDA amends the medical device reports of corrections and removals regulation to correct three inaccurate cross-references.

Human Drugs

House Bill to Make Biosimilars Fast Track Law

Legislation introduced by Reps. Diana DeGette (D-CO) and Tom Reed (R-NY) seeks to make permanent a new FDA policy that was put in place in December to...

Human Drugs

Merck Multiple Sclerosis Drug Approved

FDA approves a Merck EMD Serono NDA for Mavenclad (cladribine) tablets to treat relapsing forms of multiple sclerosis in adults.

Human Drugs

FTC Order Against Impax Anticompetitive Agreement

The Federal Trade Commission releases an opinion and final order against generic company Impax Laboratories, finding that it engaged in an illegal pay...

Federal Register

FDA Seeks to Amend Radiological Health Regs

Federal Register notice: FDA proposes to amend and repeal parts of its radiological health regulations covering recommendations for radiation protecti...

Human Drugs

Warning Letters to 4 Homeopathic Drug Makers

FDA posts Warning Letters to four companies who produce homeopathic drug products, citing them for significant GMP violations.

Human Drugs

Circassia Pharma OKs sNDA for Tudorza Pressair

FDA approves a Circassia Pharmaceuticals supplemental NDA to add new data to Tudorza Pressairs (aclidinium bromide inhalation powder) prescribing info...